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discussed their series on the treatment of acute
cholecystitis by placing a naso-biliary catheter within
the gallbladder and draining it this way rather
than surgical interventions for high-risk patients. Dr
Karigiri et al. (UK) discussed the need for early
ERCP after cholecystectomy, showing that ERCP can
be used after cholecystectomy, even in patients with
recognized common bile duct stones.
In summary, several themes through the meeting
suggested the use of aggressive surgical procedures.
However, if surgical aggression is matched by a low
complication rate and high degree of resectability, this
would seem appropriate management for a particular
malignancy and the term aggressive surgery should
probably be substituted by appropriate R0, en bloc or
complete resection. Further, surgical experience,
skill sets and patient care factors in the highly
technical area of hepatobiliary and pancreatic surgery
are creating recognition of HPB as a subspecialty
within surgery. There were symposia at this meeting
discussing the merits of specialized teaching pro-
grammes and fellowships for HPB to be formalized
so that a curriculum of knowledge and a skill set can
be developed that would be broadly applied for
trainees in HPB surgery. This would decrease the
learning curve and increase exposure of trainees to
this complex surgery. Lastly, the meeting suggested a
systems approach to HPB surgery. However, it is
clear that multimodality management requires multi-
ple individual skills such as laparoscopic, endoscopic
and open surgical techniques all being performed
by a single person. This allows for better commu-
nication with other specialties, thus making the
interdisciplinary and multiple disciplinary expertise
readily available and the formation of the HPB
multimodality team would likely improve patient
management.
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JAKOB IZBICKI
This review focuses on surgical pancreatology and
major issues discussed at the IHPBA Meeting 2006
in Edinburgh. The main topics and new studies
regarding surgical pancreatology presented at the
meeting were probiotics in acute pancreatitis (AP),
delayed gastric emptying, technical feasibility studies,
spleen-preserving distal pancreatectomy, distal pan-
createctomy, endoscopic sphincterotomy (ES) prior
to pancreatoduodenectomy (PD), survival in pancrea-
tic cancer, vessel invasion and vascular resection,
advanced tumours, pancreatic resection for metastatic
adenocarcinoma and hepatic resection in pancreatic
cancer.
Lutgendorff and colleagues described how infection
of pancreatic necrosis is caused by small bowel
bacterial overgrowth and increased intestinal perme-
ability. In an experimental rat model used by
van Minnen and co-workers, prophylactic probiotics
reduced bacterial translocation and late mortality.
Therefore probiotics might be a potential new
therapeutic approach to limit disease progression
in patients with infected pancreatic necrosis. This
is certainly a new approach deserving more atten-
tion.
Delayed gastric emptying was significantly reduced
by antecolic versus retrocolic reconstructions of
duodenojejunostomy in pylorus-preserving pancrea-
toduodenectomy (PPPD). Yamaue and colleagues
also described a reduction of postoperative morbidity,
length of presence of a nasogastric tube and a lower
hospital duration time.
In technical feasibility studies, modified pancreati-
cogastrostomy in PPPD with an isoperistaltic gastric
tube was created along the greater curvature of the
stomach. No leakage of pancreatic secretions was
detected in this trial by Costa and Lucas.
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Nakao proposed a function-preserving pancreatic
head resection with a segmental duodenectomy
(PHRSD) with no observation of operative mortality
in 40 patients who have undergone this procedure so
far. Spleen-preserving distal pancreatectomy versus
distal pancreatectomy with splenectomy in benign or
low grade malignant disease (n/74) showed a higher
effectiveness (95%) of the spleen-preserving method.
A higher complication rate as regards abdominal
infection (34% versus 18%) was found in the sple-
nectomy group. Carrere and Pradere did not examine
any significant differences in operation time, mortality
or length of hospital stay.
A meta-analysis of distal pancreatectomy with
stapler closure by Diener did not reveal a significant
difference as regards the incidence of pancreatic
fistula in comparison to hand-sutured closure. How-
ever, no randomized clinical trials exist and therefore
more studies urgently need to be performed. A
prospective multicentre study (DISPACT-TRIAL) is
planned to compare stapler closure with hand-sewn
closure with the endpoints of pancreatic fistula and
death.
Endoscopic sphincterotomy (ES) prior to pancrea-
toduodenectomy in ampullary cancer was analysed in
a retrospective trial (n/124) by Saxena and collea-
gues. The tumour recurrence rate in the ES group
after 24 months was 93% in comparison with 50% in
the controls that did not undergo ES prior to surgery.
Interestingly, the liver was the only site of recurrence
in the ES group. A survival advantage of 11 months
for the non-ES group was determined, so that ES
obviously predisposes to dissemination into the portal
circulation and development of liver metastasis.
Due to a disproportionate rate of interventions,
survival in pancreatic cancer correlates with higher
socioeconomic status. Brown proposed that future
studies need to be performed to determine whether
this actually represents inequality in access to medical
services.
Depth of portal vein invasion is a prognostic factor
for survival of pancreatic cancer. Primary unresect-
able pancreatic cancer can be down-staged, i.e.
regression of vessel invasion, by systemic chemother-
apy to be eligible for surgery. This leads to a
prolonged mean survival and is therefore an option
for patients with local unresectable status.
In advanced tumours, extended pancreatic resec-
tion with vascular resection and reconstruction was
not associated with higher mortality and morbidity as
found by Schmidt and co-workers. A new approach in
a pilot study of 10 patients with intratumoral injection
of the immunocytokine MALP-2 (macrophage activa-
tion lipopeptide-2) in unresectable tumours led to an
improved survival, making this injection an interesting
and innovative approach to treatment of pancreatic
cancer in addition to surgery.
Shrikhande pointed out that randomized clinical
trials are needed to determine the indications for
palliative Whipple resection, including resection of
liver and peritoneal metastases. Major pancreatic
surgery with extended resection in metastatic disease
could be performed safely in highly selected patients
with advanced pancreatic cancer. Interaortocaval
lymph node dissection might be an option for meta-
static but locally resectable pancreatic cancer.
Hepatic resection in pancreatic cancer was analysed
in a retrospective multicentre experience (n/40)
by Adam and colleagues. Curative hepatic resection
was associated with long-term survival, especially
in cases with improved disease-free intervals. The
median survival was 19 months and in complete
resection (R0) 31 months. Adjuvant therapy might
further increase survival time in patients with liver
metastasis.
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